ARCHIVES

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

This article is from The Cancer Letter archive.

Vol. 06 No. 14 | April 4, 1980

Download PDF Visit The Full Archive

Related Articles

Feral Mouse Colony Recompetition Given Concept Approval

November 16, 1990

UT System Chancellor to Travel to MD Anderson After Faculty Senate Survey Finds Plunging Morale

September 6, 2013

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

FDA seeks support for reorganization of cancer programs, but debate continues.

July 9, 2004

Another Potti Paper Retracted

September 16, 2011

Groups Push for CMS Coverage for LDCT Lung Screening

October 3, 2014